Lumira Ventures Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
11
- Investments
-
190
- Portfolio
-
38
- Exits
-
87
Lumira Ventures General Information
Company Description
Founded in 2007, Lumira Ventures is a venture capital firm based in Toronto, Canada. The firm prefers to invest in biotechnology, medical technologies, life sciences, oncology, information technology, digital health, and therapeutic devices sectors.
Business Details
Investor Status
Trade Association
Primary Investor Type
Corporate Office
- 141 Adelaide Street West
- Suite 770
- Toronto, Ontario M5H 3L5
- Canada
Lumira Ventures Investments (190)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Thryv Therapeutics | 03-Nov-2026 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 2 | ||
| Specific Biologics | 02-Nov-2026 | Other Healthcare Technology Systems | Pre-Clinical Trials | |||
| Navion Neurosciences | 22-Sep-2026 | Drug Discovery | Startup | |||
| Altis Labs | 17-Sep-2026 | Decision/Risk Analysis | Generating Revenue | |||
| Cour | 18-Jun-2026 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Contraline | 17-Jun-2026 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Navion | 01-Jun-2026 | Biotechnology | Stealth | |||
| Nervonik | 20-Apr-2026 | Therapeutic Devices | Generating Revenue | |||
| Endogenex | 25-Mar-2026 | Later Stage VC | Therapeutic Devices | Clinical Trials - General | ||
| Congruence Therapeutics | 03-Mar-2026 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 1 |
Lumira Ventures Exits (87)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| DEKA Biosciences | 24-Aug-2026 | Out of Business | |
| ViOptix | 15-Jul-2026 | ||
| GenEp Bio | 26-Apr-2026 | ||
| SpectraWAVE | 15-Jan-2026 | ||
| KalGene Inc | 01-Dec-2025 | ||
| EnGene Therapeutics | 14-Nov-2025 | ||
| Notch Therapeutics | 31-Mar-2025 | ||
| BAROnova | 25-Feb-2025 | ||
| Endotronix | 19-Aug-2024 | Merger/Acquisition | |
| Fusion Pharmaceuticals | 04-Jun-2024 | Merger/Acquisition |
Lumira Ventures Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
Lumira Ventures Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Lumira Ventures Co-Investors (175)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Angelini Ventures | 6 |
|
|
||
| Hatteras Venture Partners |
|
|
|||
| Johnson & Johnson JJDC |
|
|
|||
| MPM BioImpact |
|
|
|||
| OrbiMed |
|
|
Lumira Ventures FAQs
-
What is Lumira Ventures?
Founded in 2007, Lumira Ventures is a venture capital firm based in Toronto, Canada.
-
When was Lumira Ventures founded?
Lumira Ventures was founded in 2007.
-
Where is Lumira Ventures headquartered?
Lumira Ventures is headquartered in Toronto, Canada.
-
What is Lumira Ventures's total asset value?
Lumira Ventures has around in total assets under management.
-
How many investments has Lumira Ventures made?
Lumira Ventures has made 190 investments.
-
What has Lumira Ventures invested in?
Lumira Ventures has made numerous investments in companies like Thryv Therapeutics, Specific Biologics, and Navion Neurosciences within the Drug Discovery and Healthcare Technology Systems industries.
-
What has Lumira Ventures invested in recently?
Lumira Ventures's latest investment was on 03-Nov-2026 in Thryv Therapeutics, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
